FT Options’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | – | Sell |
-5,740
| Closed | -$379K | – | 95 |
|
2017
Q1 | $379K | Buy |
+5,740
| New | +$379K | 0.5% | 43 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 130 |
|
2016
Q3 | – | Sell |
-13,573
| Closed | -$1.01M | – | 146 |
|
2016
Q2 | $1.01M | Buy |
13,573
+12,188
| +880% | +$907K | 0.87% | 21 |
|
2016
Q1 | $93K | Buy |
+1,385
| New | +$93K | 0.1% | 57 |
|